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Abstract
Background: BoneTour is a campaign conducted throughout the Italian territory for the assessment of Italian
people bone status and for the prevention of osteoporosis.
Methods: A total of 7305 sequential subjects of both sexes were screened, collecting clinical data through the
FRAX™ questionnaire, and measuring heel bone stiffness by Quantitative Ultrasonography (QUS). The 10-year risk
for hip and major osteoporotic fractures was calculated taking into account personal or family history of fragility
fracture, smoking, alcohol abuse, rheumatoid arthritis, prolonged steroids assumption. Additional risk factors were
evaluated, including early menopause, poor sunlight exposure, low dietary calcium intake, physical inactivity,
number of pregnancies, months of lactation, tobacco cigarettes smoked per year, specific causes of secondary
osteoporosis. Through a correlation study, the influence of each factor on the development of osteoporosis
was analyzed.
Results: As many as 18 % of women suffer from osteoporosis, as defined by QUS T-score. The calculation of FRAX™
confirmed the weight of the already known risk factors. The correlation study revealed the significance of some
additional factors, such as hyperthyroidism, nephrolithiasis, Crohn disease, ulcerative colitis, celiac disease, poor sun
exposure, and oophorectomy before age 50.
Conclusions: The high prevalence of secondary osteoporosis in the Italian population clearly indicates the
importance of additional risk factors not yet included in the FRAX™ algorithm, for which preventive measures
should be considered. Screening campaigns may allow both early diagnosis and access to treatment.
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Background
Osteoporosis, estimated to affect 22 millions of women
and 5.5 millions of men in the European Union in 2010
[1], is known as the silent epidemic because it does not
manifest until a fracture occurs. Despite advances in risk
assessment and treatment, osteoporosis is still often
either not recognized or untreated.
FRAX™ is a widely used risk algorithm, developed by
the World Health Organization to predict the 10-year
risk of hip and major osteoporotic fractures [2–4]. FRAX
includes a concise set of clinical risk factors (e.g., Age,
sex, BMD, etc.) but dietary factors and other chronic dis-
eases potentially affecting bone mass and quality are not
included. In case DXA BMD is not available, FRAX can
be calculated based on non- BMD risk factors only.
In many parts of the world, in some countries and in
some less well-served areas, DXA is not easily available and
therefore some alternative measurements of bone strength,
i.e., ultrasound, have been suggested as a practical alterna-
tive to help raise awareness of the disease [5–9].
In this report, the results of a large epidemiological
campaign conducted via a mobile van carried out
throughout Italy in 2011 and 2012, called “BoneTour”,
are described.
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There are 3 principal aims of BoneTour campaign using
a motor home: i) to carry out a population screening in
order to identify individuals at risk for osteoporosis and to
educate them; ii) to obtain National epidemiological results
that could enable the development of prevention measures
aimed at groups at risk and iii) to correlate individual risk
factors with bone quality, assessed by Quantitative Ultra-
sonography (QUS), as well as previous fragility fractures.
Methods
BoneTour campaign and recruitment of participants
Data deriving from a screening campaign promoted by
Fondazione Italiana Ricerca Malattie Ossee (F.I.R.M.O.),
a non-profit organization devoted to the study of bone
diseases, is reported in this paper. The study was ap-
proved by the Internal Review Board of the University of
Florence. Subjects of both sexes were recruited on a
voluntary basis in major Italian cities as representative of
the different regions of belonging. Thus, no age restric-
tions or recruitment criteria were applied.
The evaluation was carried out on May-June 2011 and
on September 2012 in a mobile ambulatory (motor home)
with a staff composed by physicians, technicians and nutri-
tionists. Subjects were administered the “One Minute Risk
Test” questionnaire (https://www.iofbonehealth.org/sites/
default/files/PDFs/2012-IOF_risk_test-english[WEB].pdf),
including FRAX™ risk factors and additional questions on
different causes of secondary osteoporosis (i.e., hyperthy-
roidism, calcium nephrolithiasis, celiac disease, Crohn’s
disease, and ulcerative colitis). Further information regard-
ing number of pregnancies, months of lactation, age of
menopause, and quantified cigarette smoking (pack-years)
were also collected.
Once the individual risk of fracture was established,
the medical staff handed out practical advice for the pre-
vention of osteoporosis. After the obtainment of an in-
formed consent, data were anonymously reported into
an electronic database to allow pooled analysis.
Assessments and measurements
Quantitative ultrasonometry (QUS) was performed by
Achilles Insight (Lunar, GE), a portable, easy-to-operate,
radiation-free device suitable for low-cost, rapid, large
screening of bone status (bone density, structure and
composition) [10, 11]. Since many studies demonstrated
the association of QUS results with BMD measured by
DXA, both in men and post-menopausal women, as well
as QUS effectiveness in identifying osteoporotic subjects
and estimating their risk of femoral fracture, subjects
have been classified as normal, osteopenic and osteopor-
otic according to ultrasound T-score (> −1, between −1
and −2.4, and ≤ −2.5, respectively) [12–16].
The 2011 BoneTour (BT11) and the 2012 BoneTour
(BT12) campaigns were carried out in 3779 individuals
(belonging to 20 cities) and in 3526 subjects (17 cities)
respectively (Fig. 1). In BT12, weight and height were
also measured by a mechanical scale with an altimeter
aboard the motor home and used to calculate the body
mass index (BMI).
The questionnaire investigated the risk factors for which
numerous evidence support premenopausal and peri-
menopausal women screening: prolonged use of corti-
costeroids (≥5 mg of prednisone for 3 months or longer),
protracted amenorrhea, rheumatoid arthritis (RA), and
prolonged hyperthyroidism [17, 18]. As regards hyper-
parathyroidism (HPT), this being a condition often un-
recognized by the patient, we investigated the history of
recurrent and/or familiar nephrolithiasis, which can be as-
sociated with loss of BMD even when not due to HPT [19].
In the assessment of modifiable risk factors, some data
were provided through a dichotomous question (presence
of diseases affecting bone mass, history of oophorectomy
before age 50). Other quantitative data were collected in
the form of continuous variable, such as BMI, age of
menopause, estimated average number of cigarettes
smoked per year (reported as “pack-years”: the average
number of daily cigarette multiplied by the number of
years of smoking). Further data derived from a question
detecting the overcoming of a threshold for a healthy be-
havior: “Is your daily level of physical activity less than
30 min per day?”; “Do you regularly drink more than 2
units of alcohol a day?”; “Do you spend less than 10 min
per day exposed to sunlight?”
Data analysis
The results of the survey were pooled for the epide-
miological macroarea analysis, since the local samples were
homogeneous in size and characteristics. These data were
afterwards examined in order to calculate the 10-years risk
for hip (FRAX-B) and major osteoporotic fractures (FRAX-
A), by considering the abovementioned specific risk factors
associated with weight and height values [20]. FRAX-A
and FRAX-B were calculated for each subject by entering
in the algorithm FRAX® version 3.7 Italy model the follow-
ing data: age, sex, weight (kg), height (cm), previous frac-
ture, parent hip fracture, smoking, glucocorticoids, RA,
secondary osteoporosis, and alcohol intake ≥3 units/day.
Results are expressed as the mean ± standard deviation.
The continuous FRAX™ indicators were discretized:
the cases characterized by a FRAX™ value greater than
the average were labeled with the value “1”, the others
with “0”. Exploratory analysis of the database was per-
formed with the Statistical Package for Social Sciences
(SPSS) software release 20.0. Given the difference of sex-
frequency distribution, the comparisons operated on the
base of sex and history of fragility fracture were prepro-
cessed using a bootstrap sampling in order to balance
the subsets. The Skewness and the Kurtosis of the
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distribution allowed the use of parametric tests as infer-
ential statistics, the process of drawing conclusions from
a dataset, which is subject to random variation. Finally,
the analysis of Pearson correlations was carried out be-
tween continuous risk factors and clinical quantitative
parameters assumed as describing bone health status
(FRAX-A, FRAX-B, Z-score and T-Score). As a general
procedure, the continuous observables have been dis-
cretized properly according to the adopted statistical
analysis, if the technical requirements were fulfilled. In
order to satisfy the conditions required from the para-
metric statistics taking into account the dimension of
the study, a Monte Carlo method of Bootstrap was ap-
plied for each variable in order to extract subsamples of
comparable size, followed by the execution of the t test
or of the ANOVA test.
Results
Study group
The demographic features of the experimental sample
(BT11 and BT12, total range n =7305 subjects) are pre-
sented in Tables 1 and 2 with respect of their gender-
and age-related frequency distribution.
Females largely outnumbered males in the whole sam-
ple (n =6114, 83,7 %, versus n =1191, 16,3 %).
Regarding age, the sample showed a Gaussian distribu-
tion. Mean subject age was 58.3 ± 12.4 years (range 17–97),
in particular 57.6 ± 12.0 for women (range 17–97) and
62.0 ± 13.6 for men (range 22–92). In the female group,
3691 patients (60.4 %) were postmenopausal.
The percentage of women and men was comparable in
the two groups (women: 82.0 % in BT11 vs 85.5 % in
BT12; men: 18.0 % in BT11 vs 14.5 % in BT12).
Herein, the analysis of the whole group will be
described.
Bone status according to calcaneus ultrasonography
Regarding BMD, 18.1 % of the study group resulted
osteoporotic (age 65.3 ± 11.0, range 22–97), 42.1 %
osteopenic (age 59.4 ± 11.3, range 19–89), while 39.8 %
normal (age 54.1 ± 12.6, range17-92).
In the women subgroup, 20.2 % were osteoporotic
(age 65.2 ± 110.7, range 22–97), 44.1 % osteopenic (age
58.7 ± 11.0, range 19–89), and 35.7 % normal (age
52.0 ± 11.5, range 17–85).
In the men subgroup 7.4 % were osteoporotic (age
67.4 ± 14.1, range 25–92), 32.4 % osteopenic (age
63.9 ± 12.7, range 25–89), and 60.2 % normal (age 60.6 ±
13.5, range 22–92).
Prevalence of risk factors for osteoporosis
With regard to non-modifiable risk factors, in addition
to sex and age, genetic predisposition to develop osteo-
porosis was investigated through the detection of a past
or family history of osteoporotic fractures. When asked
if one of their parents had shown signs of osteoporosis
before the age of 75, such as kyphosis, an important de-
crease in height or a major fracture occurred in absence
of an efficient trauma (fragility fracture), as much as
25.4 % of the interviewees answered “yes”. As much as
Fig. 1 Geographic distribution of 2011 and 2012 BoneTour campaigns (BT11 and BT12, respectively), with frequency and percentual distribution
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18.3 % of the sample reported a previous fragility
fracture.
The mean age of menopause was 49.3 ± 10.1 years.
Among the group of postmenopausal women (n =3691),
23.9 % had premature ovarian failure (i.e., age of meno-
pause ≤ 45 years and negative history for hormonal re-
placement therapy).
As regards physical exercise, 19 % of the subjects
performed inadequate physical activity (i.e., less than
30 min a day).
As much as 38 % of the sample reported current or
prior tobacco smoking habit, in particular men. The
prevalence of this risk factor was also assessed for sub-
groups, with a statistically significant difference according
to sex (men 52.1 % women 35.1 %, χ2 = 121.9, p < 0.01).
Regarding alcohol intake, sun exposure and dairy
products assumption, 4.4 % of all the interviewees con-
sumed more than 2 units a day of alcoholic drinks,
24.3 % expose to sunlight for less than ten minutes a
day, 15.8 % avoided dairy products without even assum-
ing any calcium supplement.
Recurrent nephrolithiasis, hyperthyroidism, celiac dis-
ease, ulcerative colitis and Crohn’s disease were assessed
both singularly and pooled together under the name of
“secondary osteoporosis”. As a whole, secondary osteo-
porosis causes were reported by 3.9 % of the sample
(2.7 % men and 4.1 % women).
We also took into account the number of behavioral
risk factors concurrent in the same subject, finding that,
on average, each person has 2.6 ± 1.2 total risk factors
(habits), with an average for the modifiable factors of
1.5 ± 1.0. Moreover, the distribution appeared as not
“Normal” (i.e., skewedness and kurtosis are not within
the range [1, −1]); in particular, a negative exponential-
like trend was observed, making the concurrence of
Table 1 Description of the screened population: prevalence of
nominal risk factors in the general screened population and by
sex (as expressed in % and absolute number n of the total
subjects, of females and of males respectively) scalar parameters
(mean ± SD)
All Females Males
Sex 100 %
n =7305
83.7 %
n =6114
16.3 %
n =1191
Family history of osteoporosis 25.2 %
n =1839
26.2 %
n =1605
19.6 %
n =234
Previous fracture 18.3 %
n =1335
18.2 %
n =1115
18.4 %
n =220
Underweight 8.6 %
n =626
8.7 %
n =535
7.6 %
n =91
Steroids 11.6 %
n =849
11.8 %
n =725
10.4 %
n =124
Rheumatoid Arthritis 6.6 %
n =485
6.8 %
n =416
5.7 %
n =69
Nephrolithiasisa 5.5 %
n =193
5.8 %
n =175
3.5 %
n =18
Hyperthyroidisma 2.8 %
n =100
2.9 %
n =89
2.15 %
n =11
Early menopauseb - 23.9 %
885
-
Amenorrhea > 12 months - 7.3 %
446
-
Ovariectomy by age 50 - 6.8 %
418
-
Alcohol consumption 4.4 %
n =323
3.1 %
191
11.1 %
132
Smoking habit 37.9 %
n =2772
35.1 %
2151
52.1 %
621
Exercise < 30 min/day 19.0 %
n =1390
19.1 %
1169
18.5 %
221
Avoiding dairy products 15.8 %
n =1157
25.6 %
979
15.0 %
178
Exposure to sunlight 24.3 %
n =1777
25.6 %
1564
17.9 %
213
Crohn diseasea 0.2 %
n =6
0.2 %
n =5
0.2 %
n =1
Celiac diseasea 0.6 %
n =22
0.7 %
n =20
0.4 %
n =2
Rectocolitis ulcerosaa 0.3 %
n =12
0.3 %
n =10
0.4 %
n =2
Secondary osteoporosisa 3.9 %
n =138
4.1 %
n =124
2.7 %
n =14
Age (years) 58.3 ± 12.4 57.6 ± 12.0 62.00 ± 13.6
BMIa 24.6 ± 4.01 24.42 ± 4.2 25.86 ± 3.5
Menopause age (years)b - 49.41 ± 8.4 -
Pregnancies (number) - 1.29 ± 1.1 -
Lactation (months) - 8.63 ± 44.8 -
HRT (months)b - 5.75 ± 20.2 -
Smoking (pack/years) 5.9 ± 11.07 5.26 ± 10.4 10.17 ± 16.8
Mean QUS T-score −0.98 ± 4.04 −1.13 ± 4.4 −0.23 ± 4.6
Table 1 Description of the screened population: prevalence of
nominal risk factors in the general screened population and by
sex (as expressed in % and absolute number n of the total
subjects, of females and of males respectively) scalar parameters
(mean ± SD) (Continued)
Mean QUS Z-score 0.17 ± 2.01 0.07 ± 1.9 0.67 ± 3.2
Mean FRAX-A scorea (% value) 7.87 ± 7.09 8.22 ± 8.3 5.79 ± 4.6
Mean FRAX-Ba score (% value) 3.04 ± 5.09 3.14 ± 6.2 2.43 ± 3.7
Prevalence of
QUS T-score < −2.5
18,1 %
1212
20,2 %
1128
7,4 %
84
Prevalence of
QUS Z-score < −2.5
1,1 %
76
1 %
58
1,6 %
18
Prevalence of
FRAX-A score <10 %
77 %
2710
75,4 %
2266
87,1 %
444
Prevalence of
FRAX-B score <3 %
75,8 %
2653
75,7 %
2264
76,3 %
389
aAs calculated in BT12 group (subset of n =3526 subjects); bas calculated in
the group of postmenopausal women (n =3691)
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Table 2 Distribution of nominal risk factors for the considered age ranges the general screened population and by sex (as expressed in
% of the age group and absolute number, n, of subjects)
Age ranges (years) <40 40–49 50–59 60–69 70–79 ≥80 Total
% 7.4 % 14.9 % 30.1 % 28.0 % 16.3 % 3.4 % 100 %
Count (n =541) (n =1087) (n =2198) (n =2043) (n =1191) (n =245) (n =7305)
% 84.5 % 87.3 % 90.1 % 82.4 % 74.1 % 65.3 % 83.7 %
Female sex (n =457) (n =949) (n =1981) (n =1684) (n =883) (n =160) (n =6114)
% 29.7 % 30.5 % 26.5 % 23.2 % 21.3 % 13.9 % 25.17 %
Family history (n =161) (n =332) (n =584) (n =475) (n =253) (n =34) (n =1839)
% 12.0 % 13.6 % 16.3 % 18.6 % 24.6 % 36.3 % 18.3 %
Previous fracture (n =65) (n =148) (n =358) (n =381) (n =293) (n =89) (n =1334)
% 15.3 % 9.8 % 8.2 % 6.0 % 8.9 % 10.6 % 8.5 %
Underweight (n =83) (n =107) (n =180) (n =123) (n =106) (n =26) (n =625)
% 10.5 % 12.5 % 10.7 % 11.1 % 13.3 % 13.5 % 11.6 %
Steroids (n =57) (n =136) (n =236) (n =228) (n =158) (n =33) (n =848)
% 2.4 % 5.2 % 5.7 % 7.3 % 9.9 % 9.0 % 6.6 %
Rheumatoid Arthritis (n =13) (n =57) (n =125) (n =150) (n =118) (n =22) (n =485)
% 0.4 % 0.4 % 0.7 % 0.7 % 1.4 % 0.9 % 0.8 %
Nephrolithiasisa (n =1) (n =2) (n =8) (n =7) (n =8) (n =1) (n =27)
% 0 % 1 % 1.5 % 1.6 % 2.1 % 0.9 % 1.4 %
Hyperthyroidisma (n =0) (n =5) (n =16) (n =16) (n =12) (n =1) (n =50)
% 0.4 % 11.8 % 13.0 % 17.6 % 20.9 % 23.1 % 14.5 %
Early menopause (n =2) (n =112) (n =259) (n =296) (n =185) (n =37) (n =891)
% 8.3 % 8.3 % 8.8 % 5.9 % 5.9 % 4.3 % 7.4 %
Amenorrhea (n =38) (n =79) (n =174) (n =100) (n =52) (n =7) (n =450)
% 0.6 % 3.3 % 5.3 % 9.0 % 12.2 % 11.2 % 6.8 %
Ovariectomy (n =3) (n =31) (n =106) (n =153) (n =108) (n =18) (n =419)
% 5.4 % 3.0 % 4.0 % 4.9 % 5.4 % 2.8 % 4.4 %
Alcohol > 3/die (n =29) (n =33) (n =89) (n =100) (n =65) (n =7) (n =323)
% 38.0 % 35.7 % 42.0 % 38.8 % 32.4 % 30.2 % 37.9 %
Smoking (n =206) (n =388) (n =924) (n =792) (n =386) (n =74) (n =2770)
% 19.6 % 21.4 % 19.0 % 18.5 % 16.6 % 22.0 % 19.0 %
Exercise < 30’/day (n =106) (n =233) (n =419) (n =379) (n =198) (n =54) (n =1389)
% 20.7 % 16.3 % 14.5 % 16.7 % 14.0 % 15.1 % 15.8 %
Avoiding dairy products (n =112) (n =178) (n =320) (n =343) (n =167) (n =37) (n =1157)
% 24.0 % 22.8 % 24.5 % 24.8 % 24.1 % 27.3 % 24.3 %
Sunlight exposure < 10’/day (n =130) (n =248) (n =538) (n =506) (n =288) (n =67) (n =1777)
% 0.0 % 0.2 % 0.3 % 0.1 % 0.2 % 0.0 % 0.2 %
Crohn diseasea (n =0) (n =1) (n =3) (n =1) (n =1) (n =0) (n =6)
% 0.4 % 0.4 % 0.1 % 0.3 % 0.7 % 0.9 % 0.3 %
Rectocolitis ulcerosaa (n =1) (n =2) (n =1) (n =3) (n =4) (n =1) (n =12)
% 3 % 1.6 % 0.3 % 0.1 % 0.2 % 0.9 % 0.6 %
Celiac diseasea (n =8) (n =8) (n =3) (n =1) (n =1) (n =1) (n =22)
% 3.4 % 3.7 % 3.6 % 3.5 % 5.7 % 3.7 % 3.9 %
Secondary osteoporosisa (n =9) (n =18) (n =39) (n =36) (n =32) (n =4) (n =138)
aAs calculated in BT12 group (subset of n =3526 subjects)
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factors in the same person less probable when the num-
ber of factors increased. Thus, the occurrence of mul-
tiple risk factors in the same person was a rare event.
Only the 0.2 % of the sample examined showed no risk
factors at all, while the 31.5 % of the sample had no
modifiable risk factors.
FRAX was calculated in the BT12 group, comprising
3526 people, in which body weight and height were
known. Mean BMI value resulted 24.6 ± 4.01. Eighty-one
out of 3526 subjects had a BMI compatible with under-
weight, a known risk factor for osteoporosis. Indeed, the
78.6 % of the underweight subjects showed reduced (i.e.,
T-score < −1) bone stiffness independently of other risk
factors; in particular, 30 % of them showed a QUS T-score
under −2.5, 48.6 % subjects had osteopenia, and only
21.4 % had a normal T-score.
The average value reported with respect to the FRAX-A
was 7.87 ± 7.9, while the FRAX-B resulted of 3.04 ± 5.9. In
the female group FRAX-A and FRAX-B were higher than
males (FRAX-A: 8.22 ± 8.3 and 5.79 ± 4.6, in women and
men, respectively; FRAX-B: 3.14 ± 6.2 and 2.43 ± 3.7 in
women and men, respectively). Both the distributions
showed a right long tail, indicating how the majority of
the sample obtained a score near zero. Thus, 33 % of the
BT12 sample (24.6 % of women and 12.9 % of men) re-
ported FRAX-A >10 %, while 24.2 % of BT12 (24.3 % of
women and 23.7 % of men) had a FRAX-B >3 %.
Analysis of the results according to gender, previous
fracture and age
A gender analysis was performed for risk factors.
The prevalence of smoking habit resulted signifi-
cantly higher among men (53.2 %) than women
(39.1 %) (Chi2 = 35.819, p < 0.01). Similarly, the preva-
lence of declared excessive alcohol consumption appeared
strongly different between males (12.3 %) and females
(3.1 %) (Chi2 = 88.303, p < 0.01).
With respect to low sun exposure (i.e., spending less
than 10 min outdoors), women resulted significantly less
exposed to sunlight than men (26.7 and 19.2 %, respect-
ively, Chi2 = 13.220, p < 0.01).
The prevalence of risk factors was then assessed with
respect to the history of fragility fractures.
The percentage of patients with previous fractures was
greater (26.1 %) in subjects with a positive family history,
than in people with negative family history of osteopor-
osis (17.3 %) (Chi2 = 22.584, p < 0.01).
As much as 16 % of fractured subjects, versus 9.3 % of
the non-fractured ones had reported to have taken gluco-
corticoids for at least 3 consecutive months (Chi2 = 24.835,
p < 0.01).
The positive finding of previous fragility fractures was
significantly higher in subjects affected by reumathoid
arthritis (4 %) than in unaffected people (2.1 %) (Chi2 =
6.941, p < 0.01).
With respect to alcohol use/abuse the probability of
observing a previous fracture in subjects assuming at
least 3 daily units of alcohol was higher (6.7 %) than in
those who drink fewer (4 %) (Chi2 = 7.335, p < 0.01).
The incidence of fractures in women who underwent
oophorectomy before age 50 was significantly higher
(8.2 %) compared to the sample without this clinical
event (5.2 %) (Chi2 = 6.246, p < 0.01).
The conditions resulting not statistically related to age
were: steroid use, hyperthyroidism, calcium nephrolithia-
sis, physical inactivity, scarce sunlight exposure, ulcera-
tive colitis and Crohn’s disease.
In order to analyze the age effect on the observed vari-
ables of interest, the age of the subjects was discretized
along a six-levels scale (<40 years; 40–49 years; 50–59
years; 60–69 years; 70–79 years; ≥80 years) and the
prevalence of osteoporosis risk factors, an analysis of
their frequency distribution in the different age ranges
was performed (Table 3 and Fig. 2). Conversely, the other
known risk factors have a significantly different prevalence
according to the age group. Female gender shows the high-
est proportion in the sixth decade (χ2 = 222.759, p < 0.01).
Family history of osteoporosis was mostly reported in the
age range 50–59 years (χ2 = 51.685, p < 0.01). A previous
fracture was mostly present in the age range 60–69 years,
as well as rheumatoid arthritis, scarce dairy products as-
sumption and alcohol abuse, whereas smoking habit is
more common in the age group 50–59, like underweight
(χ2 = 52.319, p < 0.01); as much as 4.8 % of fractured people
in the whole sample is younger than 40.
In order to estimate the statistical relationship between
the gender and the FRAX-A score, given the unbalanced
sampling of gender, a discretization procedure should be
administered to the continuous variable FRAX-A in the
Table 3 Correlations between scalar parameters and
discretized age
Risk factor Discretized age
Pearson correlation Significance
Age at menopause 0.050 p. < 0.01
Pregnancies 0.170 p. < 0.01
Lactation (months) 0.014 ns
T-score - 0.134 p. < 0.01
Z-score 0.019 ns
HRT (months) 0.099 p. < 0.01
FRAX-A 0.605 p. < 0.01
FRAX-B 0.532 p. < 0.01
BMI 0.109 p. < 0.01
Smoking pack years 0.064 p. < 0.01
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BT12 group. The statistical relations between discretized
age and the other risk factors are reported in Table 3.
In particular, when the whole cohort FRAX-A average
score (7.87 ± 7.9) has been taken as cut-off/threshold in
order to separate the sample into two subgroups, the
10-years risk of major fractures is lower for men
(19.4 % = FRAX-A more than average value) than for
women (32.9 %) (Chi2 = 37.861, p < 0.01). Conversely,
the average scores FRAX-B does not show any signifi-
cant difference with respect to gender.
Increasing age results positively correlated to a longer
hormone replacing therapy, a major FRAX –A and –B
score, a higher BMI, number of pregnancies, and smok-
ing, while it is negatively related to T-score as measured
by heel QUS, as expected.
Parametric inferential statistics
As regards subjects assuming excessive alcohol, they re-
sulted heavier (t = −2.108, p < 0.05) and more likely smoker
than the non-drinking people (t = −3.042, p < 0.01). Note-
worthy, they also showed higher T-score values (t = −2.128,
p < 0.05).
Avoiding dairy products appeared associated with a
greater number of packs of cigarettes smoked per year
(t = −2.159, p < 0.05). Women who did not take dairy
products reported a longer duration of hormone replace-
ment therapy after menopause (t = −2.045, p < 0.05).
As expected, people affected by celiac disease were
younger (t = 2.271, p < 0.05), lighter (t = 2.561, p < 0.05)
and with a lower BMI compared to people without celiac
disease (t = 2.844, p < 0.01).
Considering physical exercise, people who declared to
do at least 30 min of daily activity was significantly
leaner (t = −3.788, p < 0.01) and with a lower pack-years
value (t = −2.714, p < 0.01) than sedentary people.
Subjects who exposed themselves to sunlight for less
than 10 min per day showed an older age (t = −2.152,
p < 0.05), a higher BMI (t = −2.201, p < 0.01), and more
importantly a more elevated FRAX-A (t = −2.210, p < 0.05)
and –B risk (t = −1.925, p = 0.05).
Women reporting history of amenorrhea protracted
more than twelve consecutive months resulted youn-
ger than those without this risk factor (t = 3.045, p <
0.01).
The cases of nephrolithiasis showed a significantly
lower T-score (t = 2.041, p < 0.05) and Z-score (t = 2.351,
p < 0.05), as well as a higher FRAX-A (t = −2.028, p < 0.05).
People who had suffered from hyperthyroidism had a
higher FRAX-A (t = −3.3, p < 0.01) and FRAX–B values
(t = −2.817, p < 0.01), and were older than people with-
out this endocrine disorder (t = −2.544, p < 0.05).
People with a previous fracture resulted heavier (t =−3.692,
p < 0.01) and older (t = −5.171, p < 0.01) than the non-
fractured people, and showed a lower T-score (t = 3.089,
p < 0.05) and a higher number of concurrent risk fac-
tors (t = −2.083, p < 0.05).
The presence of secondary osteoporosis, encompassing
a positive medical history of Crohn’s disease, ulcerative
colitis, celiac disease, hypercalciuria or hyperthyroidism,
was associated with lower T- (t = 3.073, p < 0.01) and
Z-scores (t = 2.696, p < 0.01), as well as with higher FRAX-
A (t = −4.684, p < 0.01) and FRAX–B values (t = −4.119,
p < 0.01).
Women who underwent ovariectomy by age 50 re-
sulted to have a higher FRAX-A risk (t = −2.276, p <
0.05). Noteworthy the duration of lactation did not show
any significant correlation with osteoporosis.
Fig. 2 Distribution of nominal risk factors for the considered age ranges expressed in years the general screened population (as expressed in %
of the relative age-range for each different considered factor). *As calculated in BT12 group (subset of n = 3526 subjects)
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Through a multinomial logistic regression, each risk fac-
tor was analyzed related to discretized T-score (classified
as lower or higher than mean T-score value, i.e., −0.98)
and results are reported in Table 4. Among factors belong-
ing to FRAX algorithm, female gender, family history of
osteoporosis, previous fracture, low body weight, use of
steroids, smoking habit, secondary osteoporosis resulted
significantly associated with a lower T-score; among the
other risk factors, the presence of one of the following fac-
tors including early menopause, ovariectomy by age 50,
avoiding dairy products, low exposure to sunlight, appear
to be significantly associated with lower T-score values
(Chi2 = 9.702, p < 0.01). Physical inactivity and scarce sun
exposure also show to have a certain role, although not
statistically significant (Chi2 = 3.423, p = 0.064 and Chi2 =
3.650, p = 0.056 respectively).
Discussion
Osteoporosis-related fractures are among the main
causes of adult disability in developed countries. How-
ever, bone fragility is still poorly recognized and treated,
since it may remain asymptomatic for years. For these
reasons, campaigns to assess bone status should be car-
ried out in the general population in order to identify
“at-risk” individuals. With this purpose, our screening
program was conducted to identify subjects at risk for
fragility fractures in order to plan appropriate further
testing and treatment. The BoneTour campaign targeted
all the subjects who spontaneously underwent assess-
ment of fracture risk by means of ultrasound den-
sitometry and clinical questionnaire. It involved as much
as n =7305 subjects throughout 21 Italian cities. As
regards bone status, this campaign is comparable to
ESOPO study, by which the clinical usefulness of quanti-
tative ultrasound was assessed for the first time in Italy
(2000) to define the prevalence of osteoporosis and osteo-
penia and their association with fractures [15]. In the
BoneTour sample, 18.1 % of the subjects (20.2 % of total
women and 7.4 % of total men) were osteoporotic accord-
ing to ultrasound T-score values, while 42.1 % (44.1 % of
total women and 32.4 % of total men) were osteopenic.
The majority of the sample (83.7 %) was composed by
women, and this reflects the common awareness that
female gender commonly perceives an higher risk of ex-
periencing osteoporosis and fragility fractures, either be-
cause of a smaller muscle and bone mass compared to
male, either because of the sudden drop in estrogens that
occurs with the onset of menopause. Indeed, women in
their 50s were the mainly represented category.
As a direct evidence of this difference between genders,
the average FRAX-A risk calculated for the subsample of
men resulted lower than that of women, despite the habit of
smoke and alcohol assumption resulted more incident
among males. The older mean age of males compared to fe-
males was probably due to the fact that in the collective
opinion osteoporosis is still seen as a threat only for women.
The average age of the subjects who took part in the
screening was 58.3 years, while an earlier check of bone
status would really be useful, in particular in the presence
of a risk factor. The increased risk of fracture with age is
only partly due to the reduction in BMD. Poor balance
and muscle hypotonia have an obvious role in the elderly
because they favor both sedentary lifestyle and risk of falls.
In addition, with advancing age, vitamin D insufficiency/
deficiency is becoming increasingly common and import-
ant for bone health [21]. We acknowledge that the inci-
dence of falls or the muscular performance were not
taken into account in the present analysis, and vitamin D
status was only inferred by evaluation of sun exposure.
The BoneTour database confirmed the heavy impact
that the parental history of osteoporosis has on skeleton
health [22]. Interestingly, as much as 30,5 % of people
under fifty years of age referred a family history of frac-
ture, and this prevalence seems to decrease with aging.
Analogously, most of fractured subjects declared to
have one or more notorious risk factor, such as alcohol
excessive intake, use of steroids, RA, oophorectomy be-
fore 50. In turn, previous fractures were significantly
correlated with a reduced QUS T-score, and conse-
quently a higher risk of further fractures [23].
Table 4 Logistic regression evaluating discretized T-score effect
versus nominal risk factors: likelihood ratio test
Factor Chi-square Significance
Female sex 255.97 p. < 0.01
Family history of osteoporosis 3.11 p. < 0.01
Previous fracture 1.51 p. < 0.01
Underweight 20.04 p. < 0.01
Steroids 7.21 p. < 0.05
Rheumatoid Arthritis 2.86 ns
Nephrolithiasis* 3.00 ns
Thyroid* 3.85 ns
Early menopause 47.36 p. < 0.01
Amenorrhea > 12 months 0.15 ns
Ovariectomy by age 50 44.61 p. < 0.01
Alcohol consumption 0.11 ns
Smoking habit 6.18 p. < 0.05
Exercise < 30 min/day 0.17 ns
Avoiding dairy products 10.50 p. < 0.01
Exposure to sunlight 8.85 p. < 0.05
Crohn disease* 0.74 ns
Celiac disease* 0.31 ns
Rectocolitis ulcerosa* 0.40 ns
Secondary osteoporosis* 15.20 p. < 0.01
*As calculated in BT12 group (subset of n = 3526 subjects)
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Underweight resulted associated with reduced bone
stiffness. In this respect, different studies reported con-
flicting data on the influence of BMI on BMD. A Mexican
study on postmenopausal women either with normal
weight, overweight, or different degrees of obesity revealed
that a positive and significant association between BMI
and BMD at lumbar spine, total hip and femoral neck
measured by DXA [24]. However, as reported in recent
literature, visceral adiposity has been shown to be an
independent inverse determinant of bone density in over-
weight subjects. This association may be mediated by
adipokines and a chronic inflammatory state [25]. Other
authors examined the relationship of serum leptin con-
centration with age, body weight, BMI and BMD in main-
land Chinese women, finding that age-related changes in
serum leptin concentration depends on BMI, but is not a
direct determinant of BMD [26]. Regarding underweight,
a study on adolescent female athletes found that, although
weight-bearing exercise is typically associated with an
increase in BMD, amenorrheic athletes have lower BMD
than eumenorrheic athletes and nonathletic controls,
likely as a consequence of low energy availability and sub-
sequent hypogonadism [27].
Notably, as much as 8.3 % of women aged 40–49 re-
ported the history of amenorrhea lasted over 12 months.
The loss of bone mass associated with early meno-
pause is the result of the catabolic effect of estrogen de-
ficiency, which sums the linear age-related loss of bone
mass [28]. The earlier the cessation of ovarian activity
occurs, the longer the exposition of the skeleton to the
risk of trauma, and the greater the loss of BMD in the
years to come. About 79 % of surveyed women were in
menopause. The average age of onset of menopause was
found to be 49,3 years (SD 4,6). Almost 12 % of them
had an early menopause (≤45 years), with brief or absent
hormone replacement therapy (HRT). As much as
37.4 % of early postmenopausal women resulted osteo-
penic, and 22.8 % osteoporotic.
Tobacco smoking appeared to be the most widespread
behavioral risk factor, as regarding 38 % of the sample.
Combined analysis of studies involving about 60,000
people in Canada, USA, Europe, Australia and Japan shows
that the smoking habit increases the risk of hip fracture by
1.5 times [29]. Although the risks associated with smoking
grow along with age, the effects of cigarette smoking begin
to occur early. Swedish studies showed, in a group of
young male smokers between 18 and 20 years, a reduction
in BMD and thinning of cortical bone, the component that
gives most of its strength. Thus, at a young age, smoke re-
duces the bone mass peak, increasing the risk of osteopor-
osis in later years [30]. As for alcohol assumption, the risk
of fracture related to smoking is in part due to loss of bone
stiffness, especially in women after menopause. Studies in
the UK suggest that postmenopausal smokers have a much
more rapid decline in BMD [31]. In our sample, the larger
proportion of smokers regarded the age range 50–59
(42.2 %).
One of the main behavioral protective factors is phys-
ical activity. Besides maintaining bone strength, the main
goal of exercise is to increase muscle mass and function,
as well as to maintain good balance and strength, in
order to prevent falls. In particular, resistance exercises
become even more important with increasing age, and
besides it is difficult to build bone mineral after adult-
hood, exercise has been shown to lead to modest in-
creases in BMD (1–2 %) [32]. Moreover, the correction
of sedentary lifestyle would even allow health gain as
regards the prevention of diabetes, overweight and car-
diovascular disease.
Over 19 % of the people interviewed admitted to
perform less than 30 min of physical activity per day,
including walking, gardening and housework. When re-
lated to T-score, exercise factor shows a p-value very
close to statistical significance.
It is not surprising that daily exposure to sunlight, cru-
cial for the synthesis of vitamin D, did not last more
than 10 min for over 24 % of the people. The scarce ex-
posure to sunlight may belong to a vicious cycle that
characterizes various pathological conditions affecting
the developed countries population. Indeed, sunlight in-
duces specialized light-sensitive retinal ganglion cells to
release glutamate in the suprachiasmatic nucleus, and
targets depression-associated neurotransmitter systems
(serotonin, noradrenalin, and dopamine) [33]. Psycho-
logical distress, so prevalent in our society, has been as-
sociated both with health-damaging behaviour, such as
excessive assumption of alcohol, smoking, sedentary and
unhealthy diet, both with inflammation, all of which
could increase the risk of developing a variety of path-
ologies [34], such as metabolic syndrome, cerebro- and
cardio-vascular diseases [35], as well as osteoporosis
[36]. In turn, the abovementioned pathologies can lead
people not to perform exercise, especially outdoors, fur-
ther increasing the distress condition.
Patients with RA display an increased risk of osteopor-
osis and fragility fractures [36]. Indeed this disease affected
2.38 % of our sample and presented a strong correlation
with the history of fragility fracture (p < 0.01), independ-
ently of steroid use.
Considerably, also each of the other causes of secondary
osteoporosis [37–40], i.e., Crohn’s disease, ulcerative
colitis, celiac disease, hypercalciuria and hyperthyroidism,
resulted as statistically significant in conditioning both
QUS T-score and FRAX-A and –B.
These conditions should therefore be included in the as-
sessment of fracture risk by FRAX®, in analogy with what
is reported in the English algorithm Q-fracture. This
software reports, as binary variables, “Gastrointestinal
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conditions likely to result in malabsorption (that is Crohn’s
disease, ulcerative colitis, celiac disease, steatorrhoea, blind
loop syndrome)” and “Other endocrine conditions (thyro-
toxicosis, primary or secondary hyperparathyroidism,
Cushing’s syndrome)” [41].
In literature controversial data exist about the possible
role of the number of pregnancies and breastfeeding
duration in influencing the availability of calcium to the
maternal bone [42]. In our sample, the number of preg-
nancies and the duration of lactation did not affect QUS
T-score significantly, probably because the environmen-
tal conditions protect mothers from calcium deficiency.
In summary, the results of the BoneTour 2012 cam-
paign confirmed the influence of all the variables con-
sidered by FRAX algorithm on bone status (female
gender, age, family history of osteoporosis, previous frac-
ture, underweight, alcohol abuse, secondary osteoporosis
and RA). Further factors, such as sunlight exposure,
hyperthyroidism, calcium nephrolithiasis, ovariectomy
before age 50, physical inactivity, have shown a correl-
ation with a high FRAX-score and reduced T-score.
The original version of FRAX™, based on five regional
estimates of hip fracture risk undertaken up to 20 years
previously, has been updated in 2013 on the basis of the
new fracture incidence rates reported in the Italian na-
tional hospitalization database for the year 2008 [43].
The revision resulted close to the original version, except
for a lower 10-year probability estimated in the younger
age groups, and a higher one in the oldest [43].
To verify fracture risk evaluated by BoneTour cam-
paign, a 10-year follow-up of the whole sample should
be performed, assessing the incidence of osteoporotic
fracture, as done by Lapi and colleagues [44], who
followed up a selected group of patients (aged 50–85) of
900 Primary Care Physicians until the occurrence of a
fragility fracture. This study revealed a positive associ-
ation between advanced age, history of fracture, use of
steroids, rheumatoid arthritis, underweight (BMI < 20)
and gastrointestinal disease, thus according to our data,
as well as depression, liver disease, chronic obstructive
pulmonary disease, use of anticonvulsants [44].
In light of these data, the accuracy of FRAX™ could be
improved by comparing in the long term the incidence
of occurring fractures to the risk predicted by the calcu-
lator; epidemiological studies like BoneTour campaign,
assessing bone status, history of fractures and clinical
parameters known to influence fracture risk, should be
used to increase the reliability of the algorithm.
Conclusions
The prevalence rate of osteoporosis was approximately
18.7 %, while the rate of osteopenia was about 42.6 %. The
10-year-fracture-risk calculated by FRAX™ algorithm dis-
played variation across Italy. The results confirmed the
importance of variables already present in FRAX™ (female
gender, age, family or personal history of osteoporotic
fracture, alcohol use, steroids, rheumatoid arthritis), but
showed that secondary forms of osteoporosis (Crohn dis-
ease, ulcerative colitis, hyperthyroidism, calcium nephro-
lithiasis), poor sun exposure, and of oophorectomy before
age 50 added to FRAX prediction. These conditions de-
serve to be taken into account by the physician since they
may impact bone strength. A screening campaign, as well
as being helpful for the people to assess their bone status,
raise awareness and learn how to prevent osteoporosis, is
useful for the health system, which can then modify the
intervention at the territorial and hospital level depending
on the presence of specific risk factors in that region.
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